Deciphering Immunotherapy Resistance: Targets, Mechanisms, and Therapeutic Innovations
Deadline 2026-11-16Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to announce a new Article Collection dedicated to understanding mechanisms and developing new therapeutics to combat immunotherapy resistance. Immunotherapy has transformed the landscape of modern medicine by harnessing the immune system to prevent or treat diseases. While therapeutic vaccines and immune checkpoint modulators have demonstrated remarkable success, their…
Human Microbiome and Vaccine Efficacy
Deadline 2026-11-30Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Human Microbiome and Vaccine Efficacy". This Article Collection focuses on examining the influence of the human microbiome on vaccine safety and efficacy. Recent research indicates that the composition of microflora in diverse human tissues is influenced by factors including age, ethnicity, environment, l…
Immunization and Disasters
Deadline 2026-12-01Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Immunization and Disasters". Disasters are a major challenge for infectious disease control and elimination. Disruption of food systems, degradation of housing, water supply, and waste management, and reduced functioning of transportation systems and public health institutions during and following a disas…
Advancing Immunization in China: Bridging Policy, Evidence, and Practice
Deadline 2027-02-01Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Advancing Immunization in China: Bridging Policy, Evidence, and Practice". Over the past several decades, China’s National Immunization Program (NIP) has achieved remarkable and far-reaching success, driving the incidence of numerous vaccine-preventable diseases (VPDs) to historic lows and substantially r…
Advances and Implementation Challenges in Vaccine Confidence, Access, and Immunization Programs in LMICs of the Global South
Deadline 2027-03-31Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Advances and Implementation Challenges in Vaccine Confidence, Access, and Immunization Programs in LMICs of the Global South". Vaccination programs continue to be one of the most impactful public health interventions, yet many countries in the Global South face persistent and emerging barriers that threat…
Progress Towards an Epstein-Barr Virus Vaccine
Deadline 2027-03-31Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics, in conjunction with Guest Advisors Dr. Craig Laferriere and Dr. Lawrence Young, is pleased to announce a new Article Collection dedicated to recent advances in the development of an Epstein-Barr Virus vaccine. The compelling link between Epstein-Barr virus (EBV) infection and the onset of multiple sclerosis (MS), strongly evidenced by a recent large-scale longitudinal study, pres…
Vaccines and Immunotherapy for Epstein Barr Virus, Cytomegalovirus and Related Human Herpesviruses
Deadline 2027-04-01Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Vaccines and Immunotherapy for Epstein Barr Virus, Cytomegalovirus and Related Human Herpesviruses". Human herpesviruses establish lifelong persistence, undergo periodic reactivation, and cause a wide spectrum of diseases across the lifespan, ranging from asymptomatic infection to congenital disease, infe…
Immune Reprogramming in Autoimmune Diseases
Deadline 2027-05-17Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Immune Reprogramming in Autoimmune Diseases". Autoimmune diseases arise when immune cells target auto-antigens, leading to chronic inflammation and tissue damage. The central players in many autoimmune diseases like systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis are dysregulate…
Understanding and Improving Vaccination Behaviour: Emerging Challenges, Behavioural Insights, and Interventions
Deadline 2027-07-15Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Understanding and Improving Vaccination Behaviour: Emerging Challenges, Behavioural Insights, and Interventions". Vaccination behaviour is a dynamic and multifaceted phenomenon that extends beyond the decision to accept or refuse a vaccine. It encompasses how individuals perceive vaccination, form intenti…
Evidence-Based Optimization of Worldwide Childhood Vaccination Programs
Deadline 2027-07-30Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Evidence-Based Optimization of Worldwide Childhood Vaccination Programs". Childhood vaccination programs form the backbone of global infectious disease prevention, yet uneven implementation and unmet coverage targets persist across low, middle, and high-income nations. This thematic Collection centres on…
Psychosocial Aspects of Vaccination: Understanding the Human Dimensions of Immunization
Deadline 2027-08-02Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
Human Vaccines & Immunotherapeutics is pleased to welcome you to submit your research to the Article Collection "Psychosocial Aspects of Vaccination: Understanding the Human Dimensions of Immunization". Vaccination is among the most effective public health achievements, preventing millions of deaths and substantially reducing the burden of infectious diseases globally. However, vaccine acceptance and hesitancy are n…
Real-World Evidence in COVID-19 Prevention
Deadline 2028-01-01Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
We are pleased to announce a new Article Collection in Human Vaccines & Immunotherapeutics , dedicated to the important role of real-world evidence (RWE) studies in the prevention of COVID-19. The world was taken by storm by the global COVID-19 pandemic. The scientific and medical community quickly rallied together to develop and test numerous COVID-19 vaccines of different designs, which have become a mainstay annu…
Real-World Evidence in the Prevention of Influenza
Deadline 2028-01-01Taylor & FrancisIndexed (Active)
Journal: Human Vaccines & Immunotherapeutics
We are pleased to announce a new Article Collection in Human Vaccines & Immunotherapeutics , dedicated to the important role of real-world evidence (RWE) studies in the prevention of influenza. Although considered a common infection, influenza has a relatively high mortality rate in vulnerable groups, and thus the US CDC recommends for all patients 6 months and older to receive an influenza vaccination every year. W…
Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.
DrAIStudio